Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆

Published:2004-01 Issue:1 Volume:113 Page:115-119
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Garrett Jennifer K,Jameson Sean C,Thomson Blythe,Collins Margaret H,Wagoner Lynne E,Freese Debbie K,Beck Lisa A,Boyce Joshua A,Filipovich Alexandra H,Villanueva Joyce M

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Cited by 325 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC);Cells;2024-07-11

2. Role of IL‐5 in asthma and airway remodelling;Clinical & Experimental Allergy;2024-06-27

3. Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan;Drugs;2024-06

4. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

5. Successful Introduction of Benralizumab for Eosinophilic Ascites;Biomedicines;2024-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP